Pub. Date : 2022 May 5
PMID : 35512806
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Prediction of Carboxylesterase 1 (CES1)-mediated In Vivo Drug Interaction between Methylphenidate and Cannabinoids using Static and Physiologically Based Pharmacokinetic Models. | Cannabinoids | carboxylesterase 1 | Homo sapiens |
| 2 | Prediction of Carboxylesterase 1 (CES1)-mediated In Vivo Drug Interaction between Methylphenidate and Cannabinoids using Static and Physiologically Based Pharmacokinetic Models. | Cannabinoids | carboxylesterase 1 | Homo sapiens |
| 3 | Oral MPH undergoes extensive pre-systemic metabolism by carboxylesterase 1 (CES1), a hepatic enzyme which can be inhibited by two prominent cannabinoids, 9-tetrahydrocannabinol (THC) and cannabidiol (CBD). | Cannabinoids | carboxylesterase 1 | Homo sapiens |
| 4 | Oral MPH undergoes extensive pre-systemic metabolism by carboxylesterase 1 (CES1), a hepatic enzyme which can be inhibited by two prominent cannabinoids, 9-tetrahydrocannabinol (THC) and cannabidiol (CBD). | Cannabinoids | carboxylesterase 1 | Homo sapiens |